These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8532984)

  • 21. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM
    Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients.
    Tiffon L; Coplan JD; Papp LA; Gorman JM
    J Clin Psychiatry; 1994 Feb; 55(2):66-9. PubMed ID: 8077156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of panic disorder.
    Cassano GB; Toni C; Musetti L
    Adv Biochem Psychopharmacol; 1992; 47():449-60. PubMed ID: 1509926
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
    Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA; Argyle N; Klerman GL
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surreptitious drug use by patients in a panic disorder study.
    Clark DB; Taylor CB; Roth WT; Hayward C; Ehlers A; Margraf J; Agras WS
    Am J Psychiatry; 1990 Apr; 147(4):507-9. PubMed ID: 1969248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of alprazolam, imipramine, and placebo in the treatment of depression.
    Feighner JP; Aden GC; Fabre LF; Rickels K; Smith WT
    JAMA; 1983 Jun; 249(22):3057-64. PubMed ID: 6133970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J; Schless AP
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
    Feighner JP; Meredith CH; Frost NR; Chammas S; Hendrickson G
    Acta Psychiatr Scand; 1983 Oct; 68(4):223-33. PubMed ID: 6138925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    Klein E; Colin V; Stolk J; Lenox RH
    Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E; Patterson W; Rickels K; Rosenthal M
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Soto S; Knapp E
    Acta Psychiatr Scand; 1993 Jul; 88(1):1-11. PubMed ID: 8372689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalized anxiety disorder versus panic disorder: participation in controlled efficacy trials.
    Mavissakalian MR; Zamar N
    Compr Psychiatry; 2000; 41(4):253-8. PubMed ID: 10929792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of response during placebo treatment of panic disorder.
    Mellergård M; Rosenberg NK
    Acta Psychiatr Scand; 1990 Apr; 81(4):340-4. PubMed ID: 2188481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imipramine on the treatment of chronic dizziness and panic disorder--3 cases report.
    Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):717-8. PubMed ID: 20307620
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
    Weissman MM; Prusoff B; Sholomskas AJ; Greenwald S
    J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
    Klein E; Malel D; Zilberman I; Lenox RH
    Isr J Psychiatry Relat Sci; 1997; 34(4):265-9. PubMed ID: 9409083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.